These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 733619)

  • 1. [Case of severe shock following repeated administration of rifampicin].
    Cesarz-Fronczyk M
    Pol Tyg Lek; 1978 Dec; 33(50):1935-6. PubMed ID: 733619
    [No Abstract]   [Full Text] [Related]  

  • 2. Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus.
    Martínez E; Collazos J; Mayo J
    Clin Infect Dis; 1998 Nov; 27(5):1329-30. PubMed ID: 9827298
    [No Abstract]   [Full Text] [Related]  

  • 3. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis.
    Luzzati R; Giacomazzi D; Franchi F; Barcobello M; Vento S
    South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of allergic shock caused by readministration of rifampicin].
    Hashimoto M; Yokoyama S; Taniguchi H; Higai S
    Kekkaku; 1987 Jan; 62(1):25-9. PubMed ID: 3573508
    [No Abstract]   [Full Text] [Related]  

  • 5. [Desensitization to rifampicin. Apropos of a case].
    Alonso MD; de la Hoz B; Cuevas M; Beick A
    Med Clin (Barc); 1996 Mar; 106(8):319. PubMed ID: 8667695
    [No Abstract]   [Full Text] [Related]  

  • 6. [Side effects of rifampicin in the treatment of chronic pulmonary tuberculosis by the intermittent method].
    Kost A
    Pol Tyg Lek; 1975 Mar; 30(13):557-8. PubMed ID: 1121469
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological aspects of adverse reactions during treatment with rifampicin].
    Zeană C; Bănică D; Algeorge G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(1):33-7. PubMed ID: 6264568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recurrent renal failures in continuous treatment with rifampicin].
    Löllgen H; Bolte JP
    Munch Med Wochenschr; 1973 May; 115(20):913-5. PubMed ID: 4740450
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anaphylactic shock after readministration of rifampicin: a case report].
    Chiang SR; Su WJ; Lee PY; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Dec; 50(6):509-12. PubMed ID: 1338030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abdominal variant of drug-induced anaphylactic shock].
    Lopatin AS
    Ter Arkh; 1981; 53(11):71-3. PubMed ID: 7339911
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anaphylactic shock caused by antitubercular drugs in a case of tuberculosis with primary resistance to 4 drugs].
    Rózewska M; Graczyk J
    Gruzlica; 1970 Mar; 38(3):257-60. PubMed ID: 5527050
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term intravenous rifampicin treatment. Advantages and disadvantages.
    Anker N; Band FC
    Eur J Respir Dis; 1981; 62(2):84-6. PubMed ID: 6453721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2 cases of hemolytic complications during intermittent treatment with rifampicin].
    Năstase M; Brener E; Năstase R; Borgovan L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(1):43-6. PubMed ID: 171722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of anaphylactic shock following administration of streptomycin to a pregnant woman with pulmonary tuberculosis].
    Grishchenko PI; Kunovskiĭ BV
    Vrach Delo; 1972 Oct; 10():89-90. PubMed ID: 4658422
    [No Abstract]   [Full Text] [Related]  

  • 16. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute renal failure after rifampicin (author's transl)].
    Mănescu N; Gluhovschi G; Golea O; Nicolcioiu M; Schwarzkopf A; Zosin C
    MMW Munch Med Wochenschr; 1974 Dec; 116(49):2161-6. PubMed ID: 4216838
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental and clinical studies of rifampicin in tuberculosis.
    Konno K; Oizumi K; Hayashi I; Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):110-20. PubMed ID: 5004309
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fulminant, rapidly reversible hepatitis and life-threatening anaphylaxis following rifampicin in an HIV-positive female patient with latent adrenal cortex insufficiency].
    Canova CR; Kuhn M; Zellweger U; Reinhart WH
    Schweiz Med Wochenschr; 1996 Mar; 126(10):392-7. PubMed ID: 8643939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.